Literature DB >> 33546439

Identification and Analytical Characterization of a Novel Synthetic Cannabinoid-Type Substance in Herbal Material in Europe.

Emmanouil D Tsochatzis1,2, Joao Alberto Lopes1, Margaret V Holland1, Fabiano Reniero1, Giovanni Palmieri3, Claude Guillou1.   

Abstract

The rapid diffusion of new psychoactive substances (NPS) presents unprecedented challenges to both customs authorities and analytical laboratories involved in their detection and characterization. In this study an analytical approach to the identification and structural elucidation of a novel synthetic cannabimimetic, quinolin-8-yl-3-[(4,4-difluoropiperidin-1-yl) sulfonyl]-4-methylbenzoate (2F-QMPSB), detected in seized herbal material, is detailed. An acid precursor 4-methyl-3-(4,4-difluoro-1-piperidinylsulfonyl) benzoic acid (2F-MPSBA), has also been identified in the same seized material. After extraction from the herbal material the synthetic cannabimimetic, also referred to as synthetic cannabinoid receptor agonists or "synthetic cannabinoids", was characterized using gas chromatography-mass spectrometry (GC-MS), 1H, 13C, 19F and 15N nuclear magnetic resonance (NMR) and high-resolution tandem mass spectrometry (HR-MS/MS) combined with chromatographic separation. A cheminformatics platform was used to manage and interpret the analytical data from these techniques.

Entities:  

Keywords:  2F-QMPSB; GC-MS; HR-MS/MS; NMR; cheminformatics; synthetic cannabinoids

Mesh:

Substances:

Year:  2021        PMID: 33546439      PMCID: PMC7913736          DOI: 10.3390/molecules26040793

Source DB:  PubMed          Journal:  Molecules        ISSN: 1420-3049            Impact factor:   4.411


  23 in total

1.  'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?

Authors:  Volker Auwärter; Sebastian Dresen; Wolfgang Weinmann; Michael Müller; Michael Pütz; Nerea Ferreirós
Journal:  J Mass Spectrom       Date:  2009-05       Impact factor: 1.982

2.  Discovery, characterization and biological evaluation of a novel (R)-4,4-difluoropiperidine scaffold as dopamine receptor 4 (D4R) antagonists.

Authors:  Daniel E Jeffries; Jonathan O Witt; Andrea L McCollum; Kayla J Temple; Miguel A Hurtado; Joel M Harp; Anna L Blobaum; Craig W Lindsley; Corey R Hopkins
Journal:  Bioorg Med Chem Lett       Date:  2016-10-17       Impact factor: 2.823

3.  Searching Online Chemical Data Repositories via the ChemAgora Portal.

Authors:  Antonella Zanzi; Clemens Wittwehr
Journal:  J Chem Inf Model       Date:  2017-11-30       Impact factor: 4.956

4.  Arylsulfonamides as a new class of cannabinoid CB1 receptor ligands: identification of a lead and initial SAR studies.

Authors:  N Lambeng; F Lebon; B Christophe; M Burton; M De Ryck; L Quéré
Journal:  Bioorg Med Chem Lett       Date:  2006-10-05       Impact factor: 2.823

5.  Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.

Authors:  Sebastian Dresen; Nerea Ferreirós; Michael Pütz; Folker Westphal; Ralf Zimmermann; Volker Auwärter
Journal:  J Mass Spectrom       Date:  2010-10       Impact factor: 1.982

6.  Patterns of synthetic cannabinoid use in Australia.

Authors:  Monica J Barratt; Vince Cakic; Simon Lenton
Journal:  Drug Alcohol Rev       Date:  2012-10-09

7.  Spice: a never ending story?

Authors:  Rainer Lindigkeit; Anja Boehme; Ina Eiserloh; Maike Luebbecke; Marion Wiggermann; Ludger Ernst; Till Beuerle
Journal:  Forensic Sci Int       Date:  2009-07-08       Impact factor: 2.395

8.  Arylsulfonamide CB2 receptor agonists: SAR and optimization of CB2 selectivity.

Authors:  Monika Ermann; Doris Riether; Edward R Walker; Innocent F Mushi; James E Jenkins; Beatriz Noya-Marino; Mark L Brewer; Malcolm G Taylor; Patricia Amouzegh; Stephen P East; Brian W Dymock; Mark J Gemkow; Andreas F Kahrs; Andreas Ebneth; Sabine Löbbe; Kathy O'Shea; Daw-Tsun Shih; David Thomson
Journal:  Bioorg Med Chem Lett       Date:  2008-01-18       Impact factor: 2.823

9.  Collaboration of the Joint Research Centre and European Customs Laboratories for the Identification of New Psychoactive Substances.

Authors:  Claude Guillou; Fabiano Reniero; Joana Lobo Vicente; Margaret Holland; Kamil Kolar; Hubert Chassaigne; Salvatore Tirendi; Herve Schepers
Journal:  Curr Pharm Biotechnol       Date:  2018       Impact factor: 2.837

10.  Identification of 1-Butyl-Lysergic Acid Diethylamide (1B-LSD) in Seized Blotter Paper Using an Integrated Workflow of Analytical Techniques and Chemo-Informatics.

Authors:  Emmanouil Tsochatzis; Joao Alberto Lopes; Fabiano Reniero; Margaret Holland; Jenny Åberg; Claude Guillou
Journal:  Molecules       Date:  2020-02-07       Impact factor: 4.411

View more
  2 in total

1.  In-depth comparison of the metabolic and pharmacokinetic behaviour of the structurally related synthetic cannabinoids AMB-FUBINACA and AMB-CHMICA in rats.

Authors:  David Fabregat-Safont; María Mata-Pesquera; Manuela Barneo-Muñoz; Ferran Martinez-Garcia; Marie Mardal; Anders B Davidsen; Juan V Sancho; Félix Hernández; María Ibáñez
Journal:  Commun Biol       Date:  2022-02-24

2.  Characterization of new psychoactive substances by integrating benchtop NMR to multi-technique databases.

Authors:  Thomas Castaing-Cordier; Alejandra Benavides Restrepo; Damien Dubois; Virginie Ladroue; Fabrice Besacier; Audrey Buleté; Céline Charvoz; Anais Goupille; Denis Jacquemin; Patrick Giraudeau; Jonathan Farjon
Journal:  Drug Test Anal       Date:  2022-06-26       Impact factor: 3.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.